KALA
Companies
NASDAQ
Kala Pharmaceuticals, Inc.
Health Care
$4.24
-$2.88 (-41.50%)
Price Chart
Overview
About KALA
kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at www.kalarx.com.
Market Cap
$18.5M
Volume
337.7K
Avg. Volume
347.1K
P/E Ratio
-0.5922039
Dividend Yield
0.00%
Employees
77.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.95
Moderate Correlation
Volatility
High (0.90)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, KALA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$18.5M
Volume337.7K
P/E Ratio-0.59
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025